Ametek (AME) Earnings Date & Reports
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing... Show more
AME is expected to report earnings to rise 1.02% to $1.99 per share on August 04
AMETEK (AME) Q1 2026 Earnings Recap: Record Sales and Raised Guidance
Key Takeaways
- AMETEK posted record Q1 2026 sales of $1.93 billion, up 11% year-over-year and beating consensus estimates of $1.92 billion.
- Adjusted diluted earnings per share (EPS) reached $1.97, exceeding expectations of approximately $1.90 and rising 13% from Q1 2025's $1.75.
- Orders grew 23% to record levels, bolstering a record backlog.
- Both segments delivered strong growth: Electronic Instruments Group (EIG) sales up 11% and Electromechanical Group (EMG) sales up 13%.
- Company raised full-year 2026 adjusted EPS guidance to $7.94-$8.14, from prior $7.87-$8.07.
- Adjusted operating margins expanded, with core margins up 160 basis points year-over-year.
Earnings Context and Why It Matters
AMETEK's Q1 2026 earnings are significant as they highlight the company's sustained momentum in a competitive industrial sector. Following strong Q4 2025 results, investors watched for continued execution of the AMETEK Growth Model, which emphasizes organic growth, acquisitions, and operational efficiency. With exposure to high-growth markets like aerospace, medical devices, and electrification, these results provide insights into demand trends amid economic uncertainties. Strong performance reinforces AMETEK's position as a diversified leader in electronic instruments and electromechanical systems, influencing investor confidence in its long-term compounding strategy.
Reported Results
AMETEK reported first-quarter 2026 sales of $1.93 billion, a record and 11% increase from $1.73 billion in Q1 2025. This topped analyst expectations of $1.92 billion, driven by 5% organic growth, 5 percentage points from acquisitions, and favorable foreign exchange. GAAP net income rose to $399.4 million from $351.8 million, yielding GAAP diluted EPS of $1.74, up from $1.52. Adjusted diluted EPS hit $1.97, surpassing consensus estimates around $1.90-$1.91 and up 13% year-over-year after excluding acquisition-related costs.
The EIG segment achieved sales of $1.26 billion, up 11%, with adjusted operating margins expanding 40 basis points to 31.4%. EMG set records with $664 million in sales (up 13%) and operating margins of 25.7%, up 380 basis points, fueled by robust organic growth. CEO David A. Zapico noted, "Strong organic sales growth, contributions from recent acquisitions, and outstanding operating performance led to double-digit earnings growth [and] record EBITDA."
Guidance was raised: full-year sales growth now at high single digits, adjusted EPS $7.94-$8.14 (7%-10% above 2025). Q2 adjusted EPS outlook is $1.96-$2.00.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your stock analysis workflow.
Market Reaction and Investor Sentiment
AMETEK shares edged higher following the Q1 release, reflecting positive investor response to the earnings beat, record orders, and guidance raise. The stock rose amid broad market gains, with sentiment buoyed by margin expansion and backlog strength signaling sustained demand. Analysts highlighted the outperformance in both segments as key drivers.
Forward Outlook and Key Factors to Monitor
Investors should track AMETEK's execution against its updated full-year guidance, particularly sales growth in the high single digits and adjusted EPS in the $7.94-$8.14 range. The record backlog positions the company well for revenue visibility, but conversion rates will be crucial amid potential supply chain pressures.
Segment dynamics merit attention: EIG's broad-based orders in aerospace and instrumentation suggest enduring strength, while EMG's electrification and defense exposure could benefit from geopolitical tensions. Ongoing margin discipline, including cost controls and pricing, remains vital after the quarter's expansions.
Capital deployment is another focus, with strong cash flows supporting acquisitions—recent deals contributed meaningfully this quarter. Broader industry trends like industrial automation and sustainable technologies align with AMETEK's portfolio. Monitor Q2 results for sustained organic growth and any updates on M&A (mergers and acquisitions) pipeline.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Advertisement
General Information
a manufacturer of electronic instruments and electromechanical devices
Industry IndustrialMachinery